Kopran Ltd.
BSE: 524280 | Sector: Health care |
NSE: KOPRAN | ISIN Code: INE082A01010 |
BSE 10:09 | 30 Jun | 204.35 |
-0.45 (-0.22%) |
OPEN
205.50 |
HIGH
206.95 |
LOW
203.80 |
NSE 09:59 | 30 Jun | 205.20 |
0.10 (0.05%) |
OPEN
205.10 |
HIGH
209.45 |
LOW
203.40 |
OPEN | 205.50 |
PREVIOUS CLOSE | 204.80 |
VOLUME | 532 |
52-Week high | 369.35 |
52-Week low | 176.20 |
P/E | 83.75 |
Mkt Cap.(Rs cr) | 985 |
Buy Price | 204.10 |
Buy Qty | 8.00 |
Sell Price | 205.05 |
Sell Qty | 19.00 |
Kopran Ltd. (KOPRAN) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 514.25 | -0.60 | -0.12 | 15823.68 |
Cipla | 925.80 | -19.80 | -2.09 | 13900.58 |
Dr Reddy's Labs | 4367.00 | 3.70 | 0.08 | 13349.10 |
Sun Pharma.Inds. | 838.80 | 0.65 | 0.08 | 12803.21 |
Lupin | 613.00 | -7.20 | -1.16 | 11055.93 |
Apollo Hospitals | 3738.60 | 23.40 | 0.63 | 9153.00 |
Zydus Lifesci. | 356.90 | 0.85 | 0.24 | 7790.40 |
Glenmark Pharma. | 393.15 | 4.15 | 1.07 | 7567.93 |
Alkem Lab | 2990.25 | 17.40 | 0.59 | 7219.68 |
Divi's Lab. | 3577.00 | -7.50 | -0.21 | 6798.61 |
Torrent Pharma. | 2861.45 | 21.15 | 0.74 | 6450.83 |
Ipca Labs. | 905.25 | 8.90 | 0.99 | 5114.11 |
Alembic Pharma | 729.60 | -9.25 | -1.25 | 5051.44 |
Laurus Labs | 466.95 | 0.35 | 0.08 | 4707.04 |
Abbott India | 18820.60 | -143.70 | -0.76 | 4310.02 |
Gland Pharma | 2676.35 | 24.10 | 0.91 | 3462.88 |
Glaxosmi. Pharma | 1498.55 | 0.65 | 0.04 | 3217.51 |
Granules India | 274.55 | -2.25 | -0.81 | 3134.98 |
Sanofi India | 6448.85 | 28.35 | 0.44 | 2956.60 |
Ajanta Pharma | 1253.00 | 30.15 | 2.47 | 2718.59 |
Quick Links for Kopran:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices